MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from maturities
and redemptions of...
$257,072K
Net cash provided by
(used in) investing...
$72,876K
Effect of foreign
exchange rate changes on...
$1,612K
Canceled cashflow
$184,196K
Net increase
(decrease) in cash and cash...
$21,400K
Canceled cashflow
$53,088K
Purchases of short-term
investments
$85,660K
Acquisition of in-process
research and development
$78,588K
Purchases of property and
equipment
$19,948K
Stock-based compensation
expense
$92,381K
Acquired in-process
research and development...
$75,217K
Inventories
-$24,816K
Operating leases and other
current liabilities
$19,225K
Depreciation and
amortization expense
$17,666K
Loss from equity
method investments
-$14,194K
Provision for expected
credit losses
$9,478K
Operating lease and other
impairment charges
$6,697K
Employee-related liabilities
$5,995K
Other
$4,363K
Other long-term
liabilities
$2,938K
Accounts payable
$2,227K
Amortization of debt issuance
costs
$1,860K
Net cash provided by
(used in) financing...
-$43,367K
Net cash provided by
(used in) operating...
-$9,721K
Canceled cashflow
$277,057K
Principal payments on
convertible senior notes due...
$40,760K
Cash used to settle
withholding taxes on vested...
$2,607K
Net loss
-$204,710K
Accounts receivable, net
$56,812K
Prepaid and other
current assets
$9,088K
Other long-term
assets
$6,888K
Deferred revenue
-$4,788K
Amortization of discount or
(accretion of premium) on...
$3,828K
Accrued expenses
-$664K
Back
Back
Cash Flow
source: myfinsight.com
TANDEM DIABETES CARE INC (TNDM)
TANDEM DIABETES CARE INC (TNDM)